IL1B and depressive symptom measurement: In particular, IDO has been reported to catalyze the production of kynurenine from tryptophan in the brain, causing neuroinflammation, depression, and cognitive dysfunction by activating pre-inflammatory cytokines (IFN-γ, TNF-α, IL-1, and IL-6) [41].